FDA-cleared profile

HipCheck

Stryker Corp. · Radiological images; modality varies or is not specified in FDA list · FDA-cleared (510(k))

Authorized purpose: HipCheck assists surgeons with quantitative measurements for femoroacetabular-impingement procedures by processing intraoperative static fluoroscopic images and superimposing virtual measurement tools for skeletally mature patients. HipMap FAI Analysis provides a patient-specific report for surgeon or radiologist preoperative decision-making with morphological measurements and visualizations of hip impingement and stability.

Clinical role
Intraoperative femoroacetabular-impingement measurements and preoperative patient-specific hip analysis.
Images and patients
Radiological images; modality varies or is not specified in FDA list · Hip; femoral head and neck; femoroacetabular impingement
Key limitation
Keep in mind: Use is limited to skeletally mature patients and the labeled femoroacetabular-impingement workflow; measurements and reports support but do not replace surgeon or radiologist judgment.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: HipCheck assists surgeons with quantitative measurements for femoroacetabular-impingement procedures by processing intraoperative static fluoroscopic images and superimposing virtual measurement tools for skeletally mature patients. HipMap FAI Analysis provides a patient-specific report for surgeon or radiologist preoperative decision-making with morphological measurements and visualizations of hip impingement and stability.
  • Which images or clinical context are in scope?Modality: Radiological images; modality varies or is not specified in FDA list Anatomy or clinical context: Hip; femoral head and neck; femoroacetabular impingement Input: Intraoperative static fluoroscopic X-ray images and CT scans for the patient-specific HipMap report.
  • Who uses it?Intended users: Surgeons, radiologists, and trained clinical staff.
  • What does the software produce?Output: Virtual measurement overlays, alpha-angle measurements, three-dimensional analyses, surface reconstructions, annotated images, and patient-specific reports.
  • What is its most important limitation?Key limitation: Use is limited to skeletally mature patients and the labeled femoroacetabular-impingement workflow; measurements and reports support but do not replace surgeon or radiologist judgment.

Clinical takeaway. Clinical role: HipCheck assists surgeons with quantitative measurements for femoroacetabular-impingement procedures by processing intraoperative static fluoroscopic images and superimposing virtual measurement tools for skeletally mature patients. HipMap FAI Analysis provides a patient-specific report for surgeon or radiologist preoperative decision-making with morphological measurements and visualizations of hip impingement and stability.

Evidence takeaway. Evidence from the reviewed source record: The exact FDA document reports software and bench verification, simulated-use design validation by surgeon and sales representative users, and standalone testing of an object detection AI/ML model on 745 fluoroscopic images (184 without hips; 561 of 81 hips) from 6 clinical sites against the average of two trained taggers: hip presence or absence detection 90% Lower Bound of 97.5%, and head center X coordinate within +3.3%/-3.5. No human clinical testing was conducted. Results are as reported in the FDA submission, not independent validation.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
HipCheck assists surgeons with quantitative measurements for femoroacetabular-impingement procedures by processing intraoperative static fluoroscopic images and superimposing virtual measurement tools for skeletally mature patients. HipMap FAI Analysis provides a patient-specific report for surgeon or radiologist preoperative decision-making with morphological measurements and visualizations of hip impingement and stability.
  • Exact FDA submission
  • Checked 2026-09-04
Workflow role
Intraoperative femoroacetabular-impingement measurements and preoperative patient-specific hip analysis.
  • Exact FDA submission
  • Checked 2026-09-04
Required input
Intraoperative static fluoroscopic X-ray images and CT scans for the patient-specific HipMap report.
  • Exact FDA submission
  • Checked 2026-09-04
Output and clinician action
Virtual measurement overlays, alpha-angle measurements, three-dimensional analyses, surface reconstructions, annotated images, and patient-specific reports.
  • Exact FDA submission
  • Checked 2026-09-04
Care setting
Orthopedic surgical suites and preoperative hip-imaging workflows.
  • Exact FDA submission
  • Checked 2026-09-04
Intended users
Surgeons, radiologists, and trained clinical staff.
  • Exact FDA submission
  • Checked 2026-09-04
Limitations
Use is limited to skeletally mature patients and the labeled femoroacetabular-impingement workflow; measurements and reports support but do not replace surgeon or radiologist judgment.
  • Exact FDA submission
  • Checked 2026-09-04
Evidence summary
The exact FDA document reports software and bench verification, simulated-use design validation by surgeon and sales representative users, and standalone testing of an object detection AI/ML model on 745 fluoroscopic images (184 without hips; 561 of 81 hips) from 6 clinical sites against the average of two trained taggers: hip presence or absence detection 90% Lower Bound of 97.5%, and head center X coordinate within +3.3%/-3.5. No human clinical testing was conducted. Results are as reported in the FDA submission, not independent validation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Testing included software and bench verification testing, as well as design validation. Design validation testing was conducted in a simulated-use environment by surgeon and sales representative users." … "No human clinical testing was conducted to determine the safety and effectiveness of HipCheck.". Read from the exact FDA decision document on 2026-11-14.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The exact FDA document reports software and bench verification, simulated-use design validation by surgeon and sales representative users, and standalone testing of an object detection AI/ML model on 745 fluoroscopic images (184 without hips; 561 of 81 hips) from 6 clinical sites against the average of two trained taggers: hip presence or absence detection 90% Lower Bound of 97.5%, and head center X coordinate within +3.3%/-3.5. No human clinical testing was conducted. Results are as reported in the FDA submission, not independent validation.
  • FDA source
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Testing included software and bench verification testing, as well as design validation. Design validation testing was conducted in a simulated-use environment by surgeon and sales representative users." … "No human clinical testing was conducted to determine the safety and effectiveness of HipCheck.". Read from the exact FDA decision document on 2026-11-14.

Reported sensitivity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-04

Sensitivity is not promoted as a product-wide endpoint. Compare only an exact endpoint, threshold, population, version, study design, and source if separately verified.

Reported specificity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-04

Specificity is not promoted as a product-wide endpoint. Compare only an exact endpoint, threshold, population, version, study design, and source if separately verified.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K230045 FDA evidence package for HipCheck

  • DesignFDA 510(k) bench, software, mechanical, electrical, simulated-use, and design-validation testing.
  • PopulationHip; femoral head and neck; femoroacetabular impingement
  • Scopeexact submission
  • Tested versionHipCheck version 1.5.6 and HipMap FAI Analysis configuration described in K230045
  • IndependenceSponsor or vendor study

K230045

The FDA summary states that no human clinical testing was conducted to determine safety and effectiveness for this submission; simulated-use testing involved surgeon and sales-representative users.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K230045 by exact native submission identifier. This does not exclude product-family, later-version, or adverse-event information.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-04

Exact-identifier review does not prove absence of all product-family safety signals.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

Reimbursement
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging or clinical service line and verify payer, site-of-service, coding, and coverage assumptions independently.
  • Service-level, not product-specific
  • Checked 2026-09-04

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

This is not a product-specific reimbursement determination. Build a local total-cost and value model and verify payer, site-of-service, coding, and coverage assumptions independently.

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Intraoperative static fluoroscopic X-ray images and CT scans for the patient-specific HipMap report.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-04 · FDA 510(k) K230045: HipCheck

  2. Routing

    Source context, not route validation: The FDA package describes transfer of C-arm X-ray images, virtual measurement overlays, CT processing for HipMap, USB and Stryker eRequest inputs, and USB, Stryker Health Cloud, or eRequest outputs.

    Scope: Exact FDA submission. This is the interface boundary described in the exact FDA package; current local compatibility, routing, identity, archive, and downtime behavior still require acceptance testing.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-04 · FDA 510(k) K230045: HipCheck

  3. AI processing

    Source context, not route validation: The FDA package describes HipCheck pre-installed on a compatible mobile touchscreen tablet and HipMap on a general-purpose computing platform or the HipCheck tablet; current hosting, service, availability, security, and local configuration remain unverified.

    Scope: Exact FDA submission. This is the release-level boundary described in the exact FDA package; current hosting, contracts, security, availability, upgrade path, and site configuration remain separate evidence.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-04 · FDA 510(k) K230045: HipCheck

  4. Returned objects

    Source context, not route validation: Virtual measurement overlays, alpha-angle measurements, three-dimensional analyses, surface reconstructions, annotated images, and patient-specific reports.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-04 · FDA 510(k) K230045: HipCheck

  5. Viewer/worklist/report

    Unresolved route: Virtual measurement overlays, alpha-angle measurements, three-dimensional analyses, surface reconstructions, annotated images, and patient-specific reports.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-04 · FDA 510(k) K230045: HipCheck

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The FDA package describes HipCheck pre-installed on a compatible mobile touchscreen tablet and HipMap on a general-purpose computing platform or the HipCheck tablet; current hosting, service, availability, security, and local configuration remain unverified.
  • Exact FDA submission
  • Checked 2026-09-04

This is the release-level boundary described in the exact FDA package; current hosting, contracts, security, availability, upgrade path, and site configuration remain separate evidence.

Integration
The FDA package describes transfer of C-arm X-ray images, virtual measurement overlays, CT processing for HipMap, USB and Stryker eRequest inputs, and USB, Stryker Health Cloud, or eRequest outputs.
  • Exact FDA submission
  • Checked 2026-09-04

This is the interface boundary described in the exact FDA package; current local compatibility, routing, identity, archive, and downtime behavior still require acceptance testing.

Training
Only surgeons, radiologists, and trained clinical staff should operate or interpret the product. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
  • Exact FDA submission
  • Checked 2026-09-04
Monitoring
Monitor K230045 by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Use is limited to skeletally mature patients and the labeled femoroacetabular-impingement workflow; measurements and reports support but do not replace surgeon or radiologist judgment.
  • Exact FDA submission
  • Checked 2026-09-04

This is buyer-facing monitoring guidance derived from the exact cleared or authorized scope; it is not a claim that the FDA package provides a live monitoring service.

Release and scope verification

Map installed model, build, options, population, anatomy, inputs, outputs, and enabled functions to K230045 before acceptance.

exact submission · checked 2026-09-04

Later product-family features are not evidence that this cleared or authorized release includes them.

Deployment boundary

The FDA package describes HipCheck pre-installed on a compatible mobile touchscreen tablet and HipMap on a general-purpose computing platform or the HipCheck tablet; current hosting, service, availability, security, and local configuration remain unverified.

exact submission · checked 2026-09-04

FDA-described deployment boundaries do not establish current hosting contracts, security controls, uptime, or local qualification.

Interoperability acceptance

The FDA package describes transfer of C-arm X-ray images, virtual measurement overlays, CT processing for HipMap, USB and Stryker eRequest inputs, and USB, Stryker Health Cloud, or eRequest outputs.

exact submission · checked 2026-09-04

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Use is limited to skeletally mature patients and the labeled femoroacetabular-impingement workflow; measurements and reports support but do not replace surgeon or radiologist judgment.

exact submission · checked 2026-09-04

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-04

No exact-product price was found in the reviewed public material; productivity or value claims require local evidence.

Lifecycle monitoring

Monitor K230045 by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Use is limited to skeletally mature patients and the labeled femoroacetabular-impingement workflow; measurements and reports support but do not replace surgeon or radiologist judgment.

exact submission · checked 2026-09-04

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes. hip arthroscopy image-measurement and planning software limits remain submission-specific.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K230045
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Radiological images; modality varies or is not specified in FDA list
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04
Anatomy
Hip; femoral head and neck; femoroacetabular impingement
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2023-09-29
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
26Fields reviewed
11Source classes checked
2Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads

Two PubMed records and one trial record name the HipCheck platform, but none reports HipCheck version 1.5.6 or otherwise links the tested software to K230045; all three records are quarantined and none is promoted. The current discovery snapshot contains 2 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, fda decision material, fda pma record, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-04 - Exact FDA submission

    No public list price for the exact cleared or authorized configuration was found. Obtain a written quote separating hardware or license basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not publicly available - checked 2026-09-04 - Exact FDA submission

    Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.

  • Installation timeline: Not yet reviewed

6 sources - 3 history items

Source ledger

  1. FDA 510(k) K230045: HipCheck

    U.S. Food and Drug Administration - Published 2023-09-29 - Accessed 2026-09-04

    Scope: identity, purpose, clinicalUse, modality, anatomy, intendedUsers, careSetting, workflowRole, input, output, limitations, evidenceSummary

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. Medicare Coverage Database

    Centers for Medicare & Medicaid Services - Accessed 2026-09-01

    Scope: coverage, codingContext

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

Research history

  1. K230045 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K253969

ADAS 3D

Adas3D Medical S.L.

Authorized purpose: ADAS 3D supports visualization and analysis of MR and CT images of the heart for individual patients with cardiovascular disease, including patients with myocardial scar from ischemic or non-ischemic heart disease. Qualified professionals may use it for cardiac calculation, quantification, visualization, pre-planning, and electrophysiology procedures; produced data support clinical decision-making and must not be used as irrefutable medical advice or for radiotherapy planning, dose calculation, or treatment delivery.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Heart; myocardial scar and cardiac structures
Decision
2026-06-29
FDA-cleared K260316

CMN Capillary Function with Oncology Virtual Expert

Cercare Medical A/S

Authorized purpose: Cercare Neurosuite with Capillary Function and Oncology Virtual Expert processes CT or MR information to provide perfusion, tissue-blood-volume, diffusion, labeling, and quantification support for adult brain glioma workflows.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain
Decision
2026-06-22
FDA-cleared K261713

Synapse PACS (7.6.0)

FUJIFILM Healthcare Americas Corporation

Synapse PACS 7.6.0 provides medical-image management and processing, including measurements, regional segmentation, clinical calculations, structured reports, comparison, fusion, and volume rendering to aid reading, interpretation, reporting, and treatment planning.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
N/A
Decision
2026-06-18
FDA-cleared K252563

Neurophet SCALE PET

Neurophet., Inc.

Authorized purpose: Brain MRI/PET registration, segmentation and quantitative PET assessment

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain
Decision
2026-05-15

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history